Advances in the Treatment of Genitourinary Cancers

Saturday, May 10 at 8:00am to 12:30pm

Continuing Medical Education

 

Course Overview

This half-day program will examine best practices for multidisciplinary management of genitourinary cancers. Through case presentations and discussion, specialists will review treatment options for prostate, bladder, and kidney cancer, and metastatic germ cell tumors.

At the conclusion of this course, attendees will be able to:

- Determine the most effective treatment options for patients with high-risk prostate cancer,
- Describe which treatments for castration-resistant prostate cancer are appropriate at which part of the cancer spectrum,
- Summarize emerging immunotherapies for metastatic renal cell carcinoma, and
- Discuss when surgery is appropriate after chemotherapy for metastatic germ cell tumors (GCT)

This educational activity is directed toward medical and radiation oncologists, urologists, surgeons, primary care physicians, and other interested providers.

 

Event Location
Joseph B. Martin Conference Center at Harvard Medical School
77 Avenue Louis Pasteur
Boston, MA


CME Credits
The Harvard Medical School is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Harvard Medical School designates this live activity for a maximum of 3.75 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity. 


For complete course information and to register, visit: www.dfbwcc.org/cme or call 800-553-3787.

Share
Subscribe
Website

http://www.dfbwcc.org/cme

Cost

Registration Fee (non-refundable): $50.00 through May 5, 2014 | $60.00 after May 5, 2014

Event Contact Phone

800-553-3787

Recent Activity

People Going


NCI CCC